Correction: Incidence of Hepatocellular Carcinoma in Texas Latinos, 1995–2010: An Update

Correction: Incidence of Hepatocellular Carcinoma in Texas Latinos, 1995–2010: An Update

Bibliographic Details
Main Author:	The Staff
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4105531/?tool=EBI

Similar Items

Correction: Incidence of Hepatocellular Carcinoma in Texas Latinos, 1995–2010: An Update.
Published: (2014-01-01)

Incidence of hepatocellular carcinoma in Texas Latinos, 1995-2010: an update.
by: Amelie G Ramirez, et al.
Published: (2014-01-01)

Incidence and risk factors for hepatocellular carcinoma in Texas Latinos: implications for prevention research.
by: Amelie G Ramirez, et al.
Published: (2012-01-01)

Statin Use Decreases the Incidence of Hepatocellular Carcinoma: An Updated Meta-Analysis
by: Antonio Facciorusso, et al.
Published: (2020-04-01)

Residential Radon Exposure and Incidence of Childhood Lymphoma in Texas, 1995–2011
by: Erin C. Peckham, et al.
Published: (2015-09-01)

Immunotherapy Updates in Advanced Hepatocellular Carcinoma
by: Amisha Singh, et al.
Published: (2021-04-01)

Correction: Management of Spontaneously Ruptured Hepatocellular Carcinomas in the Radiofrequency Ablation Era
by: The Staff
Published: (2014-01-01)

A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016
by: Su Jong Yu
Published: (2016-03-01)

An Update on Hepatocellular Carcinoma in Chronic Kidney Disease
by: Fabrizio Fabrizi, et al.
Published: (2021-07-01)

Immunotherapy for Hepatocellular Carcinoma: A 2021 Update
by: Christo Kole, et al.
Published: (2020-10-01)

Recent Updates of Transarterial Chemoembolilzation in Hepatocellular Carcinoma
by: Young Chang, et al.
Published: (2020-10-01)

Hepatocellular Carcinoma: Updates in Pathogenesis, Detection and Treatment
by: Maria L. Martínez-Chantar, et al.
Published: (2020-09-01)

Embolotherapeutic Strategies for Hepatocellular Carcinoma: 2020 Update
by: Sirish A. Kishore, et al.
Published: (2020-03-01)

Update in global trends and aetiology of hepatocellular carcinoma
by: Prashanth Rawla, et al.
Published: (2018-09-01)

Food Environments and Hepatocellular Carcinoma Incidence
by: Mimi Ton, et al.
Published: (2021-05-01)

Trends in incidence of primary brain cancer in New Zealand, 1995 to 2010
by: Stella J‐H Kim, et al.
Published: (2015-04-01)

Leaving Latinos out: the teaching of U.S. history in Texas
by: Noboa, Julio
Published: (2008)

An update on subtypes of hepatocellular carcinoma: From morphology to molecular
by: Monika Vyas, et al.
Published: (2021-01-01)

Screening for Hepatocellular Carcinoma in Chronic Hepatitis B: An Update
by: James Lok, et al.
Published: (2021-07-01)

Recent Update on the Role of Circular RNAs in Hepatocellular Carcinoma
by: Ely A, et al.
Published: (2021-01-01)

Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma
by: Ali, M.J, et al.
Published: (2022)

Recent Updates of Abbreviated MRI for Hepatocellular Carcinoma Screening
by: Jeong Woo Kim, et al.
Published: (2021-03-01)

Burden of hepatocellular carcinoma among hispanics in South Texas: a systematic review
by: John Ha, et al.
Published: (2017-04-01)

Update on extensions to the Texas interface
by: Clemens J.C.
Published: (1993-09-01)

Correction: Comparison of Hepatocellular Carcinoma miRNA Expression Profiling as Evaluated by Next Generation Sequencing and Microarray
by: The Staff
Published: (2014-01-01)

Texas Latino knowledge and attitudes toward natural resources and the environment
by: Lopez, Angelica
Published: (2006)

Hepatocellular carcinoma in Brazil: report of a national survey (Florianópolis, SC, 1995)
by: GONÇALVES Carlos S., et al.
Published: (1997-01-01)

Correction: Prediction of Post-Operative Liver Dysfunction by Serum Markers of Liver Fibrosis in Hepatocellular Carcinoma.
by: PLOS ONE Staff
Published: (2015-01-01)

Imaging for assessment of treatment response in hepatocellular carcinoma: Current update
by: Koichi Hayano, et al.
Published: (2015-04-01)

Hepatocellular carcinoma clinical update: Current standards and therapeutic strategies
by: Steven D. Colquhoun
Published: (2020-12-01)

Correction to: the role of metabolomics in hepatocellular carcinoma
by: Ashraf Khalil, et al.
Published: (2021-08-01)

Correction: Changes in Risk of Immediate Adverse Reactions to Iodinated Contrast Media by Repeated Administrations in Patients with Hepatocellular Carcinoma
by: The Staff
Published: (2014-01-01)

Correction: Comparative Analysis of TGF-β/Smad Signaling Dependent Cytostasis in Human Hepatocellular Carcinoma Cell Lines
by: The Staff
Published: (2014-01-01)

Hepatocellular Carcinoma and Associated Clinical Features in Latino and Caucasian Patients from a Single Center
by: Gabriela N. Kuftinec, et al.
Published: (2019-01-01)

Correction: Association of Genetic Polymorphisms with the Susceptibility to Hepatocellular Carcinoma (HCC) in Chinese Population Evaluated by an Updated Systematic Meta-Analysis.
by: Kui Liu, et al.
Published: (2014-01-01)

Correction: Development of a New Risk Score for Incident Type 2 Diabetes Using Updated Diagnostic Criteria in Middle-Aged and Older Chinese
by: The Staff
Published: (2014-01-01)

Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update
by: Tae-Hyung Kim, et al.
Published: (2019-09-01)

Surveillance, Diagnosis, and Treatment Outcomes of Hepatocellular Carcinoma in Japan: 2021 Update
by: Masatoshi Kudo
Published: (2021-05-01)

Update of NACA history - 1995-1999
by: R.Y Stephenson
Published: (1999-12-01)

Correction: Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib.
by: PLOS ONE Staff
Published: (2020-01-01)